Todd S. Thomson's most recent trade in Actuate Therapeutics Inc. was a trade of 15,000 Stock Options done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Actuate Therapeutics Inc | Todd S. Thomson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 15,000 | 15,000 | - | - | Stock Options | |
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 1,058,318 | 1,105,636 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 1,058,318 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 726,163 | 726,163 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 726,163 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 230,597 | 230,597 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 230,597 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 146,870 | 873,033 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 146,870 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 138,889 | 138,889 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 138,889 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 132,908 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 132,908 | 271,797 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 69,445 | 1,175,081 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 69,445 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 49,984 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 49,984 | 321,781 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 28,464 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 28,464 | 1,203,545 | - | 5.3 | 150,005 | Common Stock | |
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 24,138 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | 12 Aug 2024 | 24,138 | 254,735 | - | - | Common Stock | ||
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 18,750 | 1,184,795 | - | 8 | 150,000 | Common Stock |
| Actuate Therapeutics Inc | Todd S. Thomson | Director, 16.4% Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 15,000 | 15,000 | - | - | Non-Qualified Stock Options |